Glaxosmithkline Consumer Healthcare Holdings DBA Haleon 2023-02-01 Health critical FDA
Health · FDA · Recall #FDA-D-0183-2023
Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever… Recall
Issued February 1, 2023 · Glaxosmithkline Consumer Healthcare Holdings DBA Haleon
In February 2023, Glaxosmithkline Consumer Healthcare Holdings DBA Haleon recalled the Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever…, a critical health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
What you should do
- 1 Stop using Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Glaxosmithkline Consumer Healthcare Holdings DBA Haleon to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Glaxosmithkline Consumer Healthcare Holdings DBA Haleon
- Category
- Health
- Recall date
- February 1, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA.
- Recall number
- FDA-D-0183-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Glaxosmithkline Consumer Healthcare Holdings DBA Haleon has 2 recalls in our database, including 2 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.